Animal in vitro diagnostics is widely regarded as the most effective method for identifying and characterizing various chronic diseases in animals. Several diagnostic methods are used to detect diseases, including molecular diagnostic, immunodiagnostic, clinical biochemistry, urinalysis, and others.

The global Animal IVD market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Animal IVD Industry Forecast” looks at past sales and reviews total world Animal IVD sales in 2022, providing a comprehensive analysis by region and market sector of projected Animal IVD sales for 2023 through 2029. With Animal IVD sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal IVD industry.

This Insight Report provides a comprehensive analysis of the global Animal IVD landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Animal IVD portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal IVD market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal IVD and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal IVD.

• United States market for Animal IVD is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
• China market for Animal IVD is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
• Europe market for Animal IVD is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Animal IVD players cover Heska, Zoetis, Antech (Mars), Eurofins Ingenasa, IDEXX, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of the Animal IVD market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Immunodiagnosis
• Clinical Biochemistry and Molecular Diagnosis
• Hematology
• Other

Segmentation by Application:

• Pet Hospital
• Animal Husbandry and Veterinary System
• Zoo
• Research Institute Animal Experiment Center
• Animal and Plant Quarantine Department
• Others

This report also splits the market by region:

1. Americas
   • United States
   • Canada
   • Mexico
   • Brazil
2. APAC
   • China
   • Japan
   • Korea
   • Southeast Asia
   • India
   • Australia
3. Europe
   • Germany
   • France
   • UK
   • Italy
   • Russia
4. Middle East & Africa
   • Egypt
   • South Africa
   • Israel
   • Turkey
   • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Heska
• Zoetis
• Antech (Mars)
• Eurofins Ingenasa
• IDEXX
• Bio-Rad
• Thermo Fisher Scientific
• Randox
• Idvet
• Edan Instruments
• Micropointbio
• Mnchip
• Seamaty
• Digifluidic
• Mindrayanimal
• Wondfo Biotech
• Dymind
• Shenzhen Pukang Electronic Co., Ltd.
• Genrui-bio
• Tecom-cn
• USTAR
• Dawnsailbio
• Quicking
• Coyotebio
• Anheal
• Shenzhen Gangzhu Medical Technology Co., Ltd.
• Sansure Biotech
• Dian Diagnostics